Work

Lipoxin A4: a new direction in asthma therapy?

Year: 2013

Type: article

Abstract: Asthma continues to be a common and significant disease with substantial medical and economic unmet needs despite current therapies. In view of this medical and social imperative, the pathobiology ...

Source: Expert Review of Clinical Immunology

DOI: 10.1586/eci.13.36

Authors: Cindy Barnig, Bruce D Levy

Institutions: Hôpitaux Universitaires de Strasbourg, Brigham and Women's Hospital

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases

Awards: Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology, G4627662371, Lipoxins in Severe Asthma (LIPSA), AMSA: ALXR/FBR Mediated Signaling in Severe Asthma, G6072357826, G6438031073

OpenAlex ID: W2004774380

FWCI: 0.621

Cites: 17

Cited by: 16

Related to: 10